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Abstract
AIM: To document the epidemiologic patterns and risk 
factors of human immunodeficiency virus (HIV) and 
hepatitis C virus (HCV) infections in Mali in order to 
develop prevention means for both diseases.
METHODS: Two prospective studies were conducted 
in Bamako in 2009 among 1000 pregnant women (i.e. , 
young women) who consulted six reference health 
centers, and in 2010, among 231 older women who 
attended general practice in two hospitals. Antibody 
tests and molecular analysis (performed only for HCV) 
were used to quantify the frequencies of both infec-
tions. The data were collected from patients recruited 
through a questionnaire. Transmission risk factors of 
both diseases were identified by univariate and multi-
variate analysis. 
RESULTS: HCV seroprevalence was 0.2% for young 
and 6.5% for older women. HIV prevalence was similar 
in both populations (4.1% vs  6.1%). In older women, 
the analysis of risk factors highlighted an association 
between HCV infection and episodes of hospitaliza-
tion (P  < 0.01). The study did not show an association 
between HIV infection and the variables such as hos-
pitalization, transfusion, tattoo, dental care, and en-
doscopy. A significant decrease of HIV seroprevalence 
was detected in young women who used condoms for 
contraception more than for other purposes (P  < 0.01). 
By contrast, HIV seroprevalence was significantly in-
creased in young women using condoms mainly to 
prevent sexual infections rather than for contraception 
(P  < 0.01). No HCV/HIV coinfection was detected in 
our study.
CONCLUSION: Risk factors and epidemiologic data 
of HIV and HCV as well as the absence of co-infection 
strongly suggest epidemiological disparities between 
these diseases.
© 2013 Baishideng. All rights reserved.
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emerged early, there is already a notable increase of  
the incidence of  hepatic complications. In Mali, HCV 
studies have been mostly conducted among specific 
populations such as blood donors, patients suffering 
from chronic hepatitis or hemodialysis patients[3-5]. Stud-
ies on the extent and epidemiology of  HCV infection 
in the general Malian population are not abundant. The 
present study aims to document epidemiologic patterns, 
risk factors and modes of  transmission shared by both 
diseases in Mali using the epidemiologic data previously 
published by our group[6].
MATERIALS AND METHODS
Patients
Two populations of  Malian women were analyzed to char-
acterize their serological status toward both HIV (screen-
ing and confirmation tests) and HCV [screening, serologi-
cal confirmation, search for HCV-RNA by polymerase 
chain reaction (PCR) and genotyping]. Samples of  serum 
and plasma were prepared from venous whole blood.
The first series included 1000 young women who at-
tended antenatal clinics in the 6 health reference centers 
(named Ⅰ to Ⅵ) located in Bamako. The second set con-
sisted in 231 older women (over 50 years) attending the 
consultations of  general medicine in two hospitals (Cen-
tre Hospitalier Mère-Enfant and CHU Gabriel Touré) 
located in Bamako. Patients with physical or mental con-
dition precluding investigation as well as those treated 
with heparin (inhibitor of  PCR) were excluded from the 
study. This work was carried out in accordance with the 
Declaration of  Helsinki (2000) of  the World Medical 
Association. This study was approved ethically under the 
reference number 08-0006/INRSP-CE (Ethical Com-
mittee of  National Institute of  Public Health) of  Mali. 
All participating subjects remained anonymous and gave 
voluntarily informed consent.
Questionnaire on risk factors of HIV and HCV infections
A questionnaire was used to collect information about 
behaviours at risk or potentially at risk among all partici-
pants and the data were analyzed in order to identify risk 
factors for the transmission of  both infections. Since 
Trypanosomiasis may interfere with HCV serology, it 
was searched for through specific questions allowing 
presumptive diagnosis[7]. To this end, the participants 
were asked whether they presented symptoms such as 
sleep problems, anorexia or skin rash.
The residence of  the subjects was defined as fol-
lows: urban (municipalities of  Bamako district or chief  
town of  administrative region) or rural (areas outside 
both Bamako district and chief  town of  administrative 
region). Mali includes 8 administrative regions in addition 
to the Bamako district. The variables studied in the ques-
tionnaire were divided into two groups: (1) The socio-
demographic and professional characteristics: age, parity, 
gravidity, marital status, occupation of  the woman and 
the husband or partner, extent of  knowledge of  both 
HCV and HIV infections, use of  condom (yes-no) and 
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Core tip: In Mali, hepatitis C virus (HCV) studies have 
been mostly conducted among specific populations 
such as blood donors, patients suffering from chronic 
hepatitis or hemodialysis patients. Studies on the ex-
tent and epidemiology of HCV infection in the general 
Malian population are not abundant. The present study 
demonstrates that the risk factors classically associated 
to HCV infection, such as transfusion, are not dominant 
in this African population. The data presented in this 
paper have important implications in designing effective 
prevention strategies for human immunodeficiency virus 
and HCV infections.
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INTRODUCTION
Human immunodeficiency virus (HIV) infection is prop-
agated mainly through blood transfusion (before 1985), 
intravenous drug use, professional exposure in medi-
cal personnel, sexual transmission and mother-to-child 
transmission. Hepatitis C virus (HCV) contamination is 
also caused by intravenous drug use and blood transfu-
sion (before 1991), while vertical transmission accounts 
for less than 5% of  the cases and sexual transmission is 
exceptional[1]. Historically, HCV infection has developed 
in three waves: via medical care through needles and sy-
ringes reused without sterilization, via blood transfusion 
before 1991, and finally through intravenous drug injec-
tion or the sharing of  straws for cocaine inhalation[2]. In 
industrialized countries, the risk of  HCV transmission 
by blood transfusion is currently controlled by the mea-
sures taken to secure blood donation: clinical selection, 
screening of  infectious markers among blood donors 
and application of  viral inactivation processes. Drug ad-
diction is now the major mode for transmission of  HCV 
infection in industrialized countries[2]. The geographical 
distribution of  HCV is variable, with areas of  high prev-
alence such as Africa and Asia where the prevalence may 
exceed 10%, and low endemic regions such as North 
America or Western Europe with prevalence around 
1%. The high prevalence of  HCV infection in develop-
ing countries is mainly due to iatrogenic transmission 
occurred during injections in campaigns of  treatment 
or mass vaccination. A well-known case is Egypt where 
campaigns of  anti-schistosomiasis were undertaken from 
1920 to 1980. HCV propagation still represents a major 
public health problem in developing countries in which 
high HCV prevalence is associated with suboptimal 
blood safety[2].
In countries where historically HCV epidemy has 
reason to use it, education (instruction level), residence 
(urban, rural), frequency of  travel for husband or partner, 
frequency of  travel for woman; and (2) Clinical history 
and clinical informations: knowledge of  their HIV and/
or HCV status before entering the study, parasitosis (Try-
panosomiasis)[7], clinical history and medical treatments: 
heparin (PCR inhibitor), infibulation, hospitalization, 
transfusion, dialysis, dental care, fibroscopy, proctoscopy; 
socio-cultural practices: tattooing/scarification/piercing, 
excision, haircut visit of  the husband or partner.
Screening and confirmation of infection with HIV and 
HCV
The HIV third generation rapid testing VIKIA 1/2 (Bio-
Mérieux) was used for HIV screening. Positive screened 
samples were confirmed by using the INNO-LIA 
HIV Ⅰ/Ⅱ Score (Innogenetics)[6].
HCV mixed MONOLISA Ab/Ag Ultra test was 
used for both antibody and viral antigen detection in the 
serum or plasma of  recruited patients. The results were 
analyzed in triplicates and samples found positive two or 
three times [i.e., with test ratio (TR) ≥ 1] were confirmed 
by LIA HCV Score Ⅲ v2 (Innogenetics). The results 
were interpreted according to the instructions given by 
the manufacturers. HCV samples confirmed positive by 
LIA were analyzed by molecular biology (HCV Cobas 
Monitor, Roche or Abbott Real Time HCV). Samples 
tested positive by Monolisa but negative by LIA and thus 
suspect of  early infection were also analyzed by molecu-
lar methods. HCV genotyping was determined using 
Versant HCV Genotype Assay LiPA test from Siemens 
Healthcare Diagnostics[6].
Statistical analysis
Results are presented as mean ± SD (range) for continu-
ous variables and as frequency (%) for categorical vari-
ables. Comparisons of  categorical variables were assessed 
between groups using the χ 2 test. With HCV and HIV 
as dependent variables, risk factors were identified by 
univariate logistic regression. In the young women sub-
population (in which all variables were studied without 
restriction linked to gravidity status or cultural context), 
multivariate logistic regression was used. Results were 
considered significant at the 5% level of  significance (P < 
0.05). Calculations were performed using SAS version 9.3 
for Windows (SAS Institute, Cary, NC, United States) and 
Statistica version 10 (Statsoft, Tulsa, OK, United States).
RESULTS
Demographic characteristics and clinical history of 
women enrolled in this study
Descriptive data for essential demographic characteris-
tics and the clinical history of  women enrolled in this 
study are summarized in Table 1. Young women aver-
aged 25.2 ± 6.3 years (range: 14-50 years) and older 
women were 62.1 ± 8.6 years old (range: 51-89 years). 
The vast majority of  young women came from urban 
areas (97.4% vs 2.6% from rural areas). Among older 
women, urban residence was also predominant (70.9% 
vs 29.1%). Transfusion history was more frequent in old 
women (7%) than in younger ones (2.1%), (P < 0.01), 
as well as hospitalization history (33.2% vs 13.8%), (P < 
0.01). A minority of  old women (15.3%) had an accurate 
knowledge of  their HIV serological status, either positive 
or negative. This proportion was higher among young 
women (58.8%). By contrast, only 4.8% of  old women 
and 1.6% of  young women were aware of  their HCV se-
rological status. As for condom use, there was a low pro-
portion of  young women (21.9%) who claimed to use 
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  Descriptive characteristics Young women (≤ 50 yr) Older women (> 50 yr)
n  (%) mean ± SD n  (%) mean ± SD
  Age (yr)          999 25.2 ± 6.3         231 62.1 ± 8.6
  Sex (women)        1000 (100)         231 (100)  
  Rural residence area            26 (2.6)              67 (29.1)
  Urban residence area          964 (97.4)         163 (70.9)
  Transfusion history            21 (2.1)           16 (7)
  Hospitalization history          137 (13.8)           76 (33.2)
  Knowledge of HIV status          577 (58.8)           35 (15.3)
  Knowledge of HCV status            16 (1.6)            11 (4.8)
  Condom use         2171 (21.9)         N/I
  Condom use for ITS/HIV prevention          113 (52.1)
  Condom use for contraception          117 (53.9)
  Marital status
  Single            77 (7.7)          N/I
  Divorced              2 (0.2)               6 (2.6)
  Married          916 (91.9)         108 (47)
  Widowed              2 (0.2)         116 (50.4)
Table 1  Demographic characteristics and clinical history among young and old women
1217 young women reported condom use; among them, 21 did not explain their motivation and 34 used 
it for contraception as well as for infections transmitted by sexual relation (ITS)/human immunodefi-
ciency virus (HIV) prevention. N/I: Not implemented in old women (cultural context); HCV: Hepatitis 
C virus. 
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it quite often. Among them, 53.9% claimed to use it for 
contraception and 52.1% for the prevention of  HIV and 
infections transmitted by sexual relation (HIV-ITS). Re-
garding marital status, 47% of  older women were mar-
ried, 50.4% were widowed and 2.6% were divorced. For 
young women, 91.9% were married, 7.7% were single, 
0.2% were widowed and 0.2% were divorced.
Prevalence of HIV and HCV infections
HCV: Our study shows that HCV antibody prevalence 
was 0.2% (2/1000) among young women and that 
HCV-RNA prevalence in that subpopulation was 0.1% 
(1/1000). Among older women, prevalence was mea-
sured at 6.5% (15/231) for HCV antibodies and 5.6% 
(13/231) for viral HCV-RNA. HCV prevalence was 
significantly higher in old women compared to younger 
ones (P < 0.01). In both series HCV genotypes 1 and 2 
were detected with a clear predominance of  genotype 
2 (84.6%). Interestingly, the INNO-LIA HCV confir-
mation test performed on positive MONOLISA HCV 
Ab/Ag samples allowed us to determine a rate of  42.9% 
and 9.5% of  false positive results for young and older 
women respectively[6]. 
HIV: HIV screening of  both young and old women al-
lowed us to determine an HIV seroprevalence of  4.1% 
and 6.1% respectively in these subpopulations[6]. 
Knowledge of the HCV or HIV serological status among 
seropositive patients
HCV: Among HCV infected patients, respectively 93.3% 
(14/15) of  older women and 100% (2/2) of  young wom-
en were unaware of  their serological status prior to the 
survey. 
HIV: While 25% (10/40) of  infected young women were 
unaware of  their HIV status, 57.1% (8/14) of  infected 
older women had no knowledge of  their HIV status prior 
to the survey. Infected old women were significantly less 
informed about HIV than younger ones (P < 0.05). 
Risk factors of HCV infection
Series of  young women: Univariate analysis of  the data 
collected in the young women cohort revealed a signifi-
cant correlation between HCV infection and age: the 
median age for HCV seronegative women was 25 years 
while the median age for HCV seropositive women was 
44.5 years OR = 1.6; 95%CI: 1.2-2.6; P < 0.01. Similarly, 
young rural women had a higher risk of  HCV infec-
tion than those from urban areas (OR = 0.03; 95%CI: 
0.002-0.43; P < 0.05). Of  note, the very low prevalence 
of  HCV infection among young women did not allow 
for a detailed analysis of  variables in relation to HCV 
status.
Series of  women > 50 years old: In older women, the 
univariate analysis (Table 2) showed a significant cor-
relation between hospitalization history and both HCV 
seropositivity and active infection. Indeed, a significant 
proportion of  older women infected with HCV (80% 
for antibodies and 84.6% for viraemia) had at least one 
hospitalization history.
In contrast to young women, HCV seropositivity 
in older women was not associated with age. Likewise, 
HCV seropositivity was not associated with urban or 
rural residence in older women (OR = 0.69; 95%CI: 
0.26-1.84; P > 0.05). Furthermore, the logistic regression 
analysis of  the HCV seropositivity according to both 
residence (rural or urban) and hospitalization history 
(yes or no), showed that the proportion of  infected old 
women was 5 times higher in cases with hospitalization 
history (OR = 13.4; P = 0.0002), while the residence 
variable had no predictive value (OR = 2.7; P = 0.13).
Interestingly, our study did not show a correlation be-
tween HCV infection and blood transfusion in older women. 
Comparison of HCV infectious risk in young and old 
women
Univariate analysis showed that prevalence of  HCV in-
fection was higher in older women compared to young 
ones. Furthermore, these older women were more 
exposed than younger ones to risk factors of  HCV in-
fection such as dental care (OR = 45; 95%CI: 10-193), 
fibroscopy (OR = 38; 95%CI: 8.7-166) and tattooing (OR 
= 37; 95%CI: 8.5-165), and these differences were highly 
significant (P < 0.01). As explained above, prevalence of  
HCV infection in young women was higher in rural areas 
while there was no difference for HCV seropositivity in 
older women with regard to rural or urban residence. 
Overall, the proportion of  HCV seropositive women was 
significantly higher in rural areas (7%) than in urban areas 
(1%), (P < 0.01). 
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  Variables Anti-HCV HCV-RNA
Negative Ind Positive OR (95%CI) P  value Negative Ind Positive OR (95%CI) P  value
  Hospitalization
     No 146 4   3 151 0   2
     Yes   64 0 12   4.13 (1.60-10.97) < 0.01   65 0 11   12.8 (2.75-59.30) < 0.01
  Transfusion
     No 196 4 14 202 0 12
     Yes   15 0   1 0.74 (0.09-5.83)    0.77   15 0   1 1.12 (0.14-9.22)    0.91
Table 2  Risk factors according to both hepatitis C virus seropositivity and active infection in older women
Ind: Indeterminate result of the INNO-LIA hepatitis C virus (HCV) confirmation test.
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Risk factors for HIV infection
Series of  young women: The median age of  HIV sero-
negative women was 25 years, which was similar to the me-
dian age of  26 years observed in the seropositive cohort. 
Univariate analysis showed an association between 
HIV infection and 9 explicative variables such as locality 
(higher prevalence of  women from Municipality Ⅱ, P = 
0.03); monogamy (low frequency of  infection, P = 0.075); 
knowledge of  sexual transmission (higher frequency of  
infection, P < 0.01); absence of  knowledge on transmis-
sion modes (low frequency of  infection, P = 0.052); 
condom use (very low frequency of  infection, P < 0.01); 
condom use for ITS/HIV prevention (higher frequency 
of  infection, P < 0.01); superior instruction level (very 
low frequency of  infection, P < 0.01); travel of  hus-
band/partner (very low frequency of  infection, P < 0.01); 
knowledge of  the infectious status (high frequency of  
infection, P = 0.059).
Two additional variables (infibulation and anorexia/
skin rash) were included because HIV seroprevalence 
was twice higher among subjects who reported infibula-
tion history or presented such symptoms.
Multivariate analysis of  these 11 variables (Table 3) 
showed (with inclusion P = 0.05 and exclusion P = 0.10): 
(1) a decrease of  the HIV infection risk among monoga-
mous married women; (2) a decrease of  the HIV infec-
tion risk among women whose husbands or partners 
travel; (3) an increase of  the HIV infection risk among 
women who used condoms for infectious diseases pre-
vention; and (4) an increase of  the risk of  HIV infection 
among women who knew that acquired immunodefi-
ciency syndrome is transmitted by sexual routes.
Series of  women > 50 years old: The median age for 
HIV seronegative women was 60 years while the median 
age for HIV seropositive women was 52 years, but the 
difference was not significant. The HIV seroprevalence 
did not change significantly with either age or locality of  
sample collection. Likewise, HIV infection was not asso-
ciated with the type of  residence. Married and widowed 
older women were significantly less affected by HIV in-
fection than divorced ones (P < 0.05). 
Comparison of  HIV infectious risk in young and old 
women: Univariate analysis showed that young women, 
who knew that HIV is spread through sexual relation 
(OR = 2.6; 95%CI: 1.3-5.3; P < 0.01), blood (OR = 2.5; 
95%CI: 1.2-5.2; P < 0.05) or from mother to child (OR 
= 2; 95%CI: 1.0-3.95; P < 0.05), were more frequently 
infected with HIV than older women who knew these 
modes of  transmission, respectively. Regarding subjects 
whose travel time exceeded 6 mo, old women were more 
frequently infected with HIV than the younger ones (11% 
vs 2%), (OR = 2.9; 95%CI: 1.04-7.9; P < 0.05). 
In contrast to what has been described for HCV, the 
proportion of  HIV infected women was not associated 
to rural or urban residence (6/92 vs 48/1120) (P > 0.05).
Comparison of  risk factors in the two subpopula-
tions: Univariate analysis (Table 4) showed that HIV 
seropositivity of  young women was associated with vari-
ables such as locality of  sample collection, knowledge of  
sexual route and dialysis, unlike old women. 
We have noted that among young women with HIV 
infection, 39% came from municipality number Ⅱ (OR = 
3.79; 95%CI: 1.2-11.6; P < 0.05). Surprisingly, it was ob-
served that HIV prevalence was higher in young women 
who knew that HIV is transmitted by sexual relation, 
compared to those who were less informed (OR = 7.5; 
95%CI: 1-55; P < 0.05). Young women who had under-
gone dialysis were also at greater risk of  HIV infection 
(OR = 24; 95%CI: 1.5-387; P < 0.05). Out of  two women 
who had undergone dialysis, one was HIV-positive and 
was aware of  her status. As expected, young women who 
used condoms were significantly less infected than those 
who did not use it (OR = 3.6; 95%CI: 2-7; P < 0.01). 
Moreover, young women who used condoms as a contra-
ceptive method were significantly less infected (OR = 0.14; 
95%CI: 0.04-0.48; P < 0.01) than those who claimed to 
use it for other purposes. On the other hand, those who 
used it to prevent HIV-ITS were significantly more in-
fected than those who claimed not to use it for this reason 
(OR = 5.5; 95%CI: 1.5-19; P < 0.01). Young women who 
reported that their partner was traveling quite often were 
paradoxically significantly less affected by HIV infection 
than those whose partner did not travel frequently (1.93% 
vs 6.22%) (OR = 0.3; 95%CI: 0.14-0.63; P < 0.01). 
In older women, divorced subjects were significantly 
more affected by HIV infection than married and wid-
owed ones (OR = 0.01; 95%CI: 0.01-0.78; P < 0.05).
Tattooing, scarification and/or piercing were not 
significantly associated with HIV infection. Likewise, the 
variables such as transfusion, hospitalization, dental care, 
excision and residence (rural or urban), were not associ-
ated with HIV infection. 
DISCUSSION
The aim of  our study was to carry out a comparative epi-
demiological analysis of  risk factors for HIV and HCV 
infections in order to develop prevention means in Mali 
for these diseases. This study is the first to make a com-
parative epidemiological analysis of  risk factors linked to 
HIV and HCV in Mali.
In this regard, two cohorts of  patients (young wom-
en and women over 50 years) were recruited in two con-
secutive periods over two years in the same geographical 
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  Variables Estimation SE OR P value
  Marital status (monogamous)   0.29 0.16 1.35 0.06
  Travel (husband/partner)   0.55 0.17 1.73   0.002
  Condom use (HIV or ITS prevention) - 0.78 0.18 0.46 < 0.01
  HIV knowledge (sexual routes) - 0.43 0.26 0.65 0.09
Table 3  Human immunodeficiency virus status - multivariate 
logistic model
HIV: Human immunodeficiency virus; ITS: Infections transmitted by 
sexual relation.
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region. Of  note, the target population was essentially 
urban, but the proportion of  old women coming from 
rural areas was higher than that of  younger ones (29.1% 
vs 2.6%) (P < 0.01). The seroprevalence of  HCV among 
young women was very low (0.2%). By contrast it was 
significantly much higher in women > 50 years (6.5%), 
(P < 0.01). This trend with age was also observed for 
the HCV viraemia (5.6% vs 0.1%). Overall, the serop-
revalence of  the Malian women population is estimated 
at 1.3%. Interestingly, Diarra et al[3] reported a serop-
revalence of  3.3% for HCV infection in Malian blood 
donors. 
In this study, we show that the proportion of  HCV 
seropositive women in Mali is significantly higher in rural 
areas (7%) than in urban regions (1%), suggesting that 
the rural residence area is a risk factor in Mali for HCV 
infection. This is confirmed in the young women sub-
population although the HCV seroprevalence was low 
in this group and those women came mostly from urban 
areas. By contrast, the seroprevalence reached a higher 
level for older women, but we could not see any asso-
ciation between HCV infection and the residence area 
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  Variables Anti-HIV
Young women (≤ 50 yr) Older women (> 50 yr)
Negative % Positive % P value Negative % Positive % P value
  Locality
     Municipality Ⅱ (CSRef)/CHU-GT (hospital) 150 15.7 16 39 149 69.6 9 64.3
     Other municipalities/CH-ME 803 84.3 25 61 0.020   65 30.4 5 35.7 0.680
  Marital status
     Single   71   7.5   5   12.2
     Divorced     2   0.2   0  0     4   1.9 2      14
     Married 877 92.2 35   85.4 101 47.4 6      43 0.027
     Widowed     1   0.1   1     2.4 0.070 108 50.7 6      43 0.022
  Knowledge of sexual routes
     No 147 16.1   1     2.5 106 63.1 9 64.3
     Yes 766 83.9 39   97.5 0.047   62 36.9 5 35.7 0.930
  Condom use
     No 751 79.2 20   51.3     N/I
     Yes 197 20.8 19   48.7  < 0.01
  Condom use to prevent HIV/ITS
     No 100 50.8   3   15.8     N/I
     Yes   97 49.2 16   84.2 0.008
  Condom use for contraception
     No   83 42.1 16   84.2     N/I
     Yes 114 57.9   3   15.8 0.002
  Travel of husband/partner
     No 482 51.4 32   78.1     N/I
     Yes 456 48.6   9   21.9 0.002
  Knowledge of the infectious status (from questionary)
     No 392 41.9 10 25 184 86.4 8 57.1
     Yes 544 58.1 30 75 0.038   29 13.6 6 42.9 0.007
  Dialysis
     No 950 99.9 40   97.6 211 99.5       14    100
     Yes     1   0.1   1     2.4 0.026     1   0.5 0        0 0.990
  Tattooing/scarification/piercing
     No 291 30.9 14   35.9 112 54.1 4 28.6
     Yes 652 69.1 25   64.1 0.510   95 45.9       10 71.4 0.075
  Transfusion
     No 925 97.9 39   97.5 197 92.5       14    100
     Yes   20   2.1   1     2.5 0.870   16   7.5 0        0 0.980
  Hospitalization
     No 816 86.1 37 90.2 141 66.5       10 71.4
     Yes 132 13.9   4   9.8 0.450   71 33.5 4 28.6 0.710
  Dental care
     No 574 60.9 21 52.5 128 60.7 8 57.1
     Yes 369 39.1 19 47.5 0.290   83 39.3 6 42.9 0.790
  Excision
     No   92   9.7   4   9.8     N/I
     Yes 859 90.3 37 90.2 0.970
  Residence area
     Rural   25   2.7   1   2.4   61 28.5 5 38.5
     Urban 919 97.3 40 97.6 0.930 153 71.5 8 61.5 0.450
Table 4  Comparison of risk factors for human immunodeficiency virus infection among young and older women
N/I: Not implemented in old women (cultural context); CSRef: Reference health center; CHU-GT: Hospital university Gabriel TOURE; CH-ME: Mother-
Child hospital; HIV: Human immunodeficiency virus.
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for this category. This discrepancy can be explained by 
a second risk factor, the hospitalization history. Indeed, 
we observed that the proportion of  hospitalized women 
is higher in older women than in young ones (33.2% vs 
13.9%). Furthermore, the logistic regression analysis 
combining residence and hospitalization risk factors 
showed that the proportion of  infected old women is 
approximately 5 times higher in previously hospitalized 
subjects (OR = 13.4; P = 0.0002), while residence was 
not significantly associated with HCV infection (OR = 
2.7; P = 0.13). This suggests that hygienic precautions in 
health care may not be well respected in rural areas.
We observed increased HCV prevalence with respect 
to age, similarly to other reports[8-10]. There was no as-
sociation between HCV seroprevalence (or viraemia) 
and gravidity or parity among young women. Older 
women are more exposed than young women to risk fac-
tors for HCV infection such as dental care, endoscopy 
(fibroscopy) and percutaneous procedures (tattooing), 
and these differences are highly significant (OR > 1; P 
< 0.01). As usually described in the literature, the origin 
of  HCV infection is unknown in about 20% of  cases. A 
very careful and thorough investigation can sometimes 
reveal a past episode of  drug addiction or a previous 
medical procedure possibly associated with transfu-
sion[2]. Nosocomial risk by itself  is difficult to assess[11]. 
History of  surgery or medical invasive procedures does 
not necessarily mean that HCV infection is nosocomial. 
Indeed, transfusion of  blood products during surgery or 
reanimation may be ignored by the patients[11]. Outside 
transfusion and organ transplants, nosocomial infection 
is essentially due to the use of  poorly sterilized materi-
als[11-20]. Estimations of  HCV transmission through 
unsafe injections in developing countries indicate that 
2.3 to 4.7 million infections should occur annually be-
cause of  such practices[2]. Some rare cases of  doctor-
to-patient transmission have also been reported during 
cardiothoracic and gynecologic surgery[21,22]. In addition, 
an important cultural practice, excision, performed usu-
ally on several women at once in non-sterile conditions, 
is common in Malian rural areas. Moreover, the excision 
has been reported as a risk factor for HCV transmission 
in Burkina Faso, a neighboring country of  Mali[23]. We 
note that approximately 90% of  young women recruited 
in our study reported to have been excised. Only 2 of  
them were HCV seropositive. Excision as a risk factor 
was not studied in older women because excision is a 
cultural taboo of  Mali, despite awareness campaigns and, 
paradoxically, the high frequency of  this practice.
Our study did not show any significant association 
between HCV infection and transfusion history among 
older women whose HCV seroprevalence is high. Simi-
lar observations were also reported by Maiga Moussa 
et al[4] who did not observe a single case of  transfusion 
history in their cohort. Indeed, in our study only one 
of  the oldest women transfused was HCV seropositive 
(6.25%), while no transfused younger women was HCV 
seropositive. Blood transfusion has been cited as the 
most important risk factor of  HCV infection among 
pregnant women in Burkina Faso[23]. Our study seems 
to indicate instead that nosocomial transmission is the 
highest risk factor of  HCV infection in Mali. Of  note, 
the proportion of  transfused subjects is low in the two 
subpopulations, 2% and 7% for young and older women 
respectively. Therefore, our present results should be 
confirmed on a larger cohort of  transfused patients.
Drug addiction is the major mode for transmission 
of  HCV infection in industrialized countries[2]. This pa-
rameter is not investigated by our study. Of  note Maiga 
Moussa et al[4] reported the absence of  drug addiction 
history in their series. 
Previous studies have highlighted a relationship be-
tween HCV seroprevalence and dialysis, independently 
of  the use of  blood products[24-27]. However, our study 
shows no association between HCV seropositivity and 
dialysis. Again, our study included very small numbers 
of  dialyzed subjects, respectively 0.2% in young women 
and 0.4% in older ones, thus precluding any definitive 
conclusions. Baby et al[5] have reported an HCV sero-
prevalence of  19.7% (13/66) in chronic hemodialysis 
patients admitted to the nephrology department of  the 
Hospital Point G in Bamako. 
In our study conducted among old women (over 50 
years), we evaluated the prevalence of  HCV infection 
at a lower rate than that reported in previous studies 
undertaken among chronic hepatitis patients (25.3%) or 
hemodialysed patients (19.7%). In addition, serological 
screening assays were not confirmed by Western blot or 
PCR analysis in these studies. Indeed, the rate of  false 
positive results of  the screening assay (MONOLISA 
HCV Ab/Ag Ultra) is close to 10% in the old women 
subpopulation[6]. The poor performance of  HCV im-
muno-assays due to false positive reactions in African 
samples was also reported in other studies[28-32].
Our study has evaluated the HIV seroprevalence 
rate at 4.1% and 6.1% respectively in young and older 
women which is higher than 1.3% reported in the Ma-
lian general population[33]. As expected, we observed the 
importance of  condom use as a factor that decreases the 
risk of  HIV transmission, in accordance with EDSM 
report (EDSM-Ⅳ 2006, final report 2007)[33]. We have 
demonstrated that HIV rate is higher in young women 
who knew that HIV is propagated by sexual relation 
compared to those who did not know it. We have also 
shown that HIV frequency is higher in young women 
who use condoms to prevent infection than those who 
use it for another reason. This is confirmed by the fact 
that HIV infection was significantly less prominent in 
young women who used condoms more as a means of  
contraception than for another reason. This raises the 
question whether recommendations related to preven-
tion such as information, education and communication 
(IEC) are well understood, correctly followed by the 
public, and diffused efficiently in the Malian population. 
The study shows that the young women who have a 
superior instruction level were significantly less infected 
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with HIV, which stresses the critical importance of  pub-
lic information in limiting HIV propagation.
Young women, who reported that their partner was 
traveling quite often, were less affected by HIV infection 
compared to those whose partners did not travel fre-
quently. This is quite paradoxical and unexpected. A high 
rate of  HIV infections was observed in the municipal-
ity number Ⅱ among young women. Indeed, in 2007, a 
support program for seropositive women was initiated in 
this health center, which resulted in increased attendance 
by these patients. 
HIV infection rate was higher in divorced women 
compared to married women and widows. Several hy-
potheses may explain this observation: women may have 
divorced because of  the unfaithfulness of  their partner 
or divorced women may have several sexual partners. 
Our observation is confirmed by EDSM report (EDSM-
Ⅳ 2006, final report 2007), that has showed that divorce 
is a risk factor for transmission of  HIV infection[33]. Ac-
cording to this study, the level of  HIV seroprevalence 
increases with the number of  sexual partners: from 1.1% 
in women who had only one sexual partner, the preva-
lence increases to 3.3% among women who had 3 or 4 
partners. Likewise, Kirere Mathe et al[34] reported that 
divorce is a risk factor of  HIV infection.
Our study showed no significant association between 
HIV infection and the excision or infibulation in young 
women. We did not observe any association between 
percutaneous procedures (tattooing, scarification or 
piercing) and HIV or HCV infection among women. 
However, these practices are not trivial and can be 
considered as risk factors for the transmission of  viral 
infection if  health and safety measures are not followed. 
Although our study focuses on women living mainly in 
urban areas (i.e., 97.37% for young women and 70.87% 
for older women), the overall proportion of  women liv-
ing with HIV, unlike HCV, does not change significantly 
according to the type of  residence. 
Interestingly the present study did not show any HIV 
and HCV coinfection. Of  note a rare HIV/HCV coinfec-
tion has been reported in the general population in south-
ern Cameroon where both infections are endemic[35].
In conclusion, our study reveals that HCV propaga-
tion is achieved mainly through medical procedures with 
contaminated supplies rather than through blood trans-
fusion while HIV transmission may be predominantly 
of  sexual origin in Mali. Our data confirms that condom 
use significantly reduces the risk of  HIV transmission. 
Furthermore, we have observed that HIV seropositive 
patients who are aware of  their serological status are 
informed about the risk of  transmission. This study sup-
ports the idea that efforts should be made to promote 
the early screening, to reinforce prevention campaigns 
(IEC) and that targeted strategies should be developed 
in order to strongly sensitize people with low instruction 
level as well as the general Malian population to the risk 
of  sexual transmission of  HIV. Among HCV infected 
patients, respectively 93.3% of  older women and 100% 
of  young women were unaware of  their serological sta-
tus. Similarly, an estimated 45% to 85% of  United States 
adults are chronically infected with HCV, yet unaware of  
their condition[36]. Efforts must be focused on screening 
and treatment in general, and specifically on reinforcing 
hygienic measures in medical centers, and mainly in rural 
areas, in order to reduce the risk of  nosocomial trans-
mission of  HCV.
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Background
Human immunodeficiency virus (HIV) infection is propagated mainly through 
blood transfusion (before 1985), intravenous drug use, professional exposure 
in medical personnel, sexual transmission and mother-to-child transmission. 
Hepatitis C virus (HCV) contamination is also caused by intravenous drug 
use and blood transfusion (before 1991), while vertical transmission accounts 
for less than 5% of the cases and sexual transmission is exceptional. In Mali, 
HCV studies have been mostly conducted among specific populations such as 
blood donors, patients suffering from chronic hepatitis or hemodialysis patients. 
Studies on the extent and epidemiology of HCV infection in the general Malian 
population are not abundant. The present study aims to document epidemio-
logic patterns, risk factors and modes of transmission shared by both diseases 
in Mali.
Research frontiers
Similarly to this study, other authors reported age as risk factor of HCV infec-
tion. In this study conducted among old women (over 50 years), the authors 
evaluated the prevalence of HCV infection at a rate of 3-4 times lower than 
those described in two other studies undertaken in Mali. These differences may 
be explained by the fact that previous studies were conducted on patients with 
chronic hepatitis or hemodialysed patients. In addition, serological screening 
assays were not confirmed by Western blot or polymerase chain reaction analy-
sis in these studies. Indeed, the rate of false positive results of the screening 
assay (MONOLISA HCV Ab/Ag Ultra) is close to 10% in the old women sub-
population, as shown here. Moreover, the excision has been reported as a risk 
factor for HCV transmission in Burkina Faso, a neighboring country of Mali. The 
authors note that approximately 90% of young women recruited in this study re-
ported to have been excised. Out of them, only 2 were HCV seropositive. Blood 
transfusion has been cited as the most important risk factor of HCV infection 
among pregnant women in Burkina Faso. This study seems to indicate instead 
that nosocomial transmission is the highest risk factor of HCV infection in Mali. 
Concerning HIV, the authors have estimated seroprevalence at 4.1% and 6.1% 
respectively in young and older women, which is higher than 1.3% reported 
previously in the Malian general population.
Innovations and breakthroughs
This study presents for the first time in Mali a comparative epidemiological 
analysis of risk factors for HIV and HCV infections and the molecular epide-
miological profile of HCV. The observed genotypes are HCV-1 and HCV-2 (with 
predominance of genotype 2). This data is also evidence of epidemiological dis-
parities for HIV and HCV transmission in Mali (HIV essentially sexual and HCV 
mainly nosocomial).
Applications
The study supports the idea that efforts should be made to reinforce prevention 
campaigns and that targeted strategies should be developed in order to strongly 
sensitize people with low instruction level as well as the general Malian popula-
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tion to the risk of sexual transmission of HIV. Among HCV infected patients, 
respectively 93.3% of older women and 100% of young women were unaware 
of their serological status. Similarly, an estimated 45% to 85% of United States 
adults are chronically infected with HCV, yet unaware of their condition. Efforts 
must be focused on screening and treatment in general, and specifically on 
reinforcing hygienic measures in medical centers, and mainly in rural areas, in 
order to reduce the risk of nosocomial transmission of hepatitis C virus. 
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